PDI, provider of market-leading infection prevention solutions, is supporting an educational events for attendees to the Association for Vascular Access Annual Scientific Meeting, being held Sept. 7-10, 2014 in National Harbor, Md.
PDI will host a Platinum Showcase Session eligible for one CE hour on Sept. 8 at 3:30pm in Room Chesapeake 4-6. The session, “Creating a Culture of Collaboration in Vascular Access: Improving Outcomes and Reducing HAIs” will be led by Ssenior vascular access specialist at the University of Arkansas and AVA president-elect, Mark Rowe, RNP, MNSc, VA-BC and vice president of clinical affairs at PDI, Hudson Garrett, PhD, MSN, MPH, FNP-BC, CSRN, VA-BC. They will provide insight on how to create better communication and collaboration efforts with the aim of reducing infections across the continuum of care.
During the show, attendees can visit PDI at booth #201 where it will be showcasing its Prevantics® line of antiseptics featuring the first and only 3.15% Chlorhexidine Gluconate (w/v) and 70% Isopropyl Alcohol (v/v) formula. The clinical efficacy of Prevantics® products are supported by more than 14 independent clinical studies, covering both adult and pediatric populations and spanning several practice areas.